An Open Label Single Arm Clinical Study on Churna basti administered in Modified Kala Basti Schedule in Amavata
Basti is considered to have multifaceted effect as it cures the diseases of Shakha,Koshta,Marmas and Sarva Avayavas.Acharya Chakrapani mentions the unique concept of Churna Basti comprising of Saindhava Lavana, Sneha, Churnas(Rasna, Vacha, Bilwa, Shatapushpa, Ela, Putika, Madanaphala, Pippali, Devadaru, Kushta), Ushnajala and Amladravya as the key ingredients. These drugs possess ushna & teekshna gunas, Deepana-Pachana, Vata Kaphahara and Shula-Shothahara properties which may help in attaining Agni deepti, Laghutva, Nirama Lakshana and Shoolahara effect.Based on this concept,the ingredients are modified and is practiced in the management of Santharpanotha vikaras like Amavata. Amavata is the disease affecting Asthi and Sandhis wherein Ama and Vata are the initiating factors in the pathogenesis. Moreover, the chief pathogenic factors, being contradictory in nature poses difficulty in planning the line of treatment. Rheumatoid Arthritis can be correlated to Amavata on the basis of etiology, pathology, therapeutic signs and symptoms. The figures of prevalence vary substantially ranging from 0.3% to 2.1% of the population, with peak incidence in the fourth decade of life. A combination of Vaishwanara choorna, Rasna Saptaka Kashaya and Dhanyamla administered in Amavata is yielding beneficial effects as the ingredients possess the properties opposite to that of Amavata and therefore acts positively on the disease. Therefore, due to wide spectrum of disease, much prevalence in the society and lack of effective medicaments the present study was planned based on this concept and statistically highly significant effects (P>0.0001) were observed in the various assessment parameters of Amavata such as Sandhishoola, Sandhishotha, Sandhistabdhata , Sandhisparsa Asahyata etc. In overall effect of therapy maximum number of patients (40.12%) got marked improvement. Therefore, Churna Basti comprising of drugs possessing properties opposite to Ama can be considered as a good remedy in the management of Amavata.
Copyright (c) 2020 International Journal of Ayurvedic Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.